Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.26 and traded as high as $2.68. Mesoblast shares last traded at $2.68, with a volume of 185 shares.
Mesoblast Price Performance
The firm’s 50-day simple moving average is $1.97 and its 200 day simple moving average is $1.26.
About Mesoblast
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Further Reading
- Five stocks we like better than Mesoblast
- How to Short a Stock in 5 Easy Steps
- Finding Hidden Gems: Unconventional Penny Stock Investing
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Price Targets on NVIDIA Rise in Front of Earnings
- What is the Australian Securities Exchange (ASX)
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
